The Online Investor

Slideshow IPOs

By The Online Investor Staff, updated Sat., Mar. 28, 4:53 PM

Slide #1. IMARA Inc. Initial Public Offering

Company: IMARA Inc.
Proposed Symbol: IMRA
Shares Offered: 4,700,000
Price Per Share: $16.00
Over-Allotment: 705,000
Description: IMARA Inc. (the "Company") (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, known as hemoglobinopathies, announced the pricing of its initial public offering of 4,700,000 shares of common stock at a public offering price of $16.00 per share, for gross proceeds of $75.2 million, before underwriting discounts and commissions and offering expenses payable by the Company. The offering is expected to close on March 16, 2020, subject to customary closing conditions. In addition, the Company has granted the underwriters an option for a period of 30 days to purchase up to 705,000 additional shares of common stock at the initial public offering price, less underwriting discounts and commissions. All shares are being offered by the Company.

IPOs: IMARA Inc.

List of IPOs in this Slideshow: Company Ticker IPO Date SCVX Corp. SCVX.U Annovis Bio, Inc ANVS AnPac Bio-Medical Science Co., Ltd. ANPC InterPrivate Acquisition Corp. IPV.U Professional Holding Corp. PFHD CITIC Capital Acquisition Corp. CCAC.U Greenrose Acquisition Corp. GNRSU Yunhong International ZGYHU Muscle Maker, Inc. GRIL Newborn Acquisition Corp. NBACU Churchill Capital Corp III CCXX.U East Stone Acquisition Corporation ESSCU dMY Technology Group, Inc DMYT.U LifeSci Acquisition Corp. LSACU IMARA Inc. IMRA

IPOs Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.